What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
The scientist’s investigation covers issues in Surgery, Radiation therapy, Internal medicine, Prostate cancer and Nuclear medicine.
His Surgery study frequently links to related topics such as Urology.
Peter Hoskin interconnects Breast cancer, Performance status and Intention-to-treat analysis in the investigation of issues within Radiation therapy.
His study connects Oncology and Internal medicine.
His work carried out in the field of Prostate cancer brings together such families of science as Placebo, Prostate, Radiology and Brachytherapy.
His research investigates the link between Nuclear medicine and topics such as Magnetic resonance imaging that cross with problems in Cancer, Oxygenation, Carbogen Breathing, Blood flow and Multiparametric Magnetic Resonance Imaging.
His most cited work include:
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer (1817 citations)
- The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. (895 citations)
- Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy (722 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Radiation therapy, Internal medicine, Brachytherapy, Oncology and Radiology.
Radiation therapy is a primary field of his research addressed under Surgery.
His work on Bladder cancer, Hypoxia and Carcinoma as part of his general Internal medicine study is frequently connected to Hazard ratio, thereby bridging the divide between different branches of science.
The Brachytherapy study combines topics in areas such as Cervical cancer, Prostate cancer and Nuclear medicine.
He combines subjects such as Prostate and Urology with his study of Prostate cancer.
The Lung cancer research Peter Hoskin does as part of his general Oncology study is frequently linked to other disciplines of science, such as In patient, therefore creating a link between diverse domains of science.
He most often published in these fields:
- Radiation therapy (39.78%)
- Internal medicine (30.38%)
- Brachytherapy (25.00%)
What were the highlights of his more recent work (between 2018-2021)?
- Radiation therapy (39.78%)
- Radiology (23.92%)
- Brachytherapy (25.00%)
In recent papers he was focusing on the following fields of study:
Peter Hoskin focuses on Radiation therapy, Radiology, Brachytherapy, Internal medicine and Prostate cancer.
His research on Radiation therapy also deals with topics like
- Hypoxia and related Carbogen,
- Disease together with Intensive care medicine.
His Radiology research is multidisciplinary, incorporating elements of Urethral stricture, Cohort and Cervix.
His studies deal with areas such as Cervical cancer, Proportional hazards model, Median follow-up and Common Terminology Criteria for Adverse Events as well as Brachytherapy.
His research investigates the connection between Internal medicine and topics such as Oncology that intersect with problems in Clinical trial.
He has researched Prostate cancer in several fields, including Magnetic resonance imaging, Clinical endpoint, Prostate and Urology.
Between 2018 and 2021, his most popular works were:
- Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial (98 citations)
- EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort† (36 citations)
- EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees (34 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Radiation therapy
His primary areas of study are Radiation therapy, Radiology, Brachytherapy, Prostate cancer and Bladder cancer.
His Radiation therapy study is concerned with Internal medicine in general.
His work deals with themes such as Tumor size, Event free survival, Biochemical recurrence and Hodgkin lymphoma, which intersect with Radiology.
His study in Brachytherapy is interdisciplinary in nature, drawing from both Radiation treatment planning, Urology, Cervical cancer, Common Terminology Criteria for Adverse Events and Cohort.
His work in Prostate cancer addresses issues such as Prostate, which are connected to fields such as Subclinical infection and Pelvic radiotherapy.
The concepts of his Bladder cancer study are interwoven with issues in Delphi method and Oncology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
